A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice

Direct costs of radiotherapy for rectal cancer: a microcosting study

(2015) Paul Hanly et al.   BMC HEALTH SERVICES RESEARCH

Clinical Utility of Random Anti-Tumor Necrosis Factor Drug-Level Testing and Measurement of Antidrug Antibodies on the Long-Term Treatment Response in Rheumatoid Arthritis

(2015) Meghna Jani et al.   Arthritis & Rheumatology

Significant associations of antidrug antibody levels with serum drug trough levels and therapeutic response of adalimumab and etanercept treatment in rheumatoid arthritis

(2014) Der-Yuan Chen et al.   ANNALS OF THE RHEUMATIC DISEASES

Economics of Stratified Medicine in Rheumatoid Arthritis

(2014) Sean Gavan et al.   Current Rheumatology Reports

The immunogenicity of anti-TNF therapy in immune-mediated inflammatory diseases: a systematic review of the literature with a meta-analysis

(2012) Sandra Garcês et al.   ANNALS OF THE RHEUMATIC DISEASES

Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long-term Follow-up

(2011) Geertje M. Bartelds   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A microcosting study of diagnostic tests for the detection of coronary artery disease in the Netherlands

(2008) S.S. Tan et al.   EUROPEAN JOURNAL OF RADIOLOGY